Hubbry Logo
Placental abruptionPlacental abruptionMain
Open search
Placental abruption
Community hub
Placental abruption
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Placental abruption
Placental abruption
Placental abruption
View on Wikipedia
from Wikipedia
Placental abruption
Other namesAbruptio placentae
Drawing of internal and external bleeding from placental abruption
SpecialtyObstetrics
SymptomsVaginal bleeding, low abdominal pain, dangerously low blood pressure[1]
ComplicationsMother: disseminated intravascular coagulopathy, kidney failure[2]
Baby: low birthweight, preterm delivery, stillbirth[2]
Usual onset24 to 26 weeks of pregnancy[2]
CausesUnclear[2]
Risk factorsSmoking, preeclampsia, prior abruption[2]
Diagnostic methodBased on symptoms, ultrasound[1]
Differential diagnosisPlacenta previa, bloody show, chorioamnionitis[3]
TreatmentBed rest, delivery[1]
MedicationCorticosteroids[1]
Frequency~0.7% of pregnancies[2]

Placental abruption is when the placenta separates early from the uterus, in other words separates before childbirth.[2] It occurs most commonly around 25 weeks of pregnancy.[2] Symptoms may include vaginal bleeding, lower abdominal pain, and dangerously low blood pressure.[1] Complications for the mother can include disseminated intravascular coagulopathy and kidney failure.[2] Complications for the baby can include fetal distress, low birthweight, preterm delivery, and stillbirth.[2][3]

The cause of placental abruption is not entirely clear.[2] Risk factors include smoking, pre-eclampsia, prior abruption (the most important and predictive risk factor), trauma during pregnancy, cocaine use, and previous cesarean section.[2][1] Diagnosis is based on symptoms and supported by ultrasound.[1] It is classified as a complication of pregnancy.[1]

For small abruption, bed rest may be recommended, while for more significant abruptions or those that occur near term, delivery may be recommended.[1][4] If everything is stable, vaginal delivery may be tried, otherwise cesarean section is recommended.[1] In those less than 36 weeks pregnant, corticosteroids may be given to speed development of the baby's lungs.[1] Treatment may require blood transfusion or emergency hysterectomy.[2]

Placental abruption occurs in about 1 in 200 pregnancies.[5] Along with placenta previa and uterine rupture it is one of the most common causes of vaginal bleeding in the later part of pregnancy.[6] Placental abruption is the reason for about 15% of infant deaths around the time of birth.[2] The condition was described at least as early as 1664.[7]

Signs and symptoms

[edit]

In the early stages of placental abruption, there may be no symptoms.[1] When symptoms develop, they tend to develop suddenly. Common symptoms include:

  • sudden-onset abdominal pain[5][8]
  • contractions that seem continuous and do not stop[5]
  • vaginal bleeding[5][8]
  • enlarged uterus (disproportionate to the gestational age of the fetus)[5]
  • decreased fetal movement[5]
  • decreased fetal heart rate.[5]

Vaginal bleeding, if it occurs, may be bright red or dark.[1]

A placental abruption caused by arterial bleeding at the center of the placenta leads to sudden development of severe symptoms and life-threatening conditions including fetal heart rate abnormalities, severe maternal hemorrhage, and disseminated intravascular coagulation (DIC). Those abruptions caused by venous bleeding at the periphery of the placenta develop more slowly and cause small amounts of bleeding, intrauterine growth restriction, and oligohydramnios (low levels of amniotic fluid).[9]

Risk factors

[edit]
  • Pre-eclampsia[8][10]
  • Chronic hypertension[8][11]
  • Short umbilical cord[12]
  • Premature rupture of membranes[8]
  • Prolonged rupture of membranes (>24 hours).[11]
  • Thrombophilia[10]
  • Polyhydramnios[8]
  • Multiparity[10]
  • Multiple pregnancy[10]
  • Maternal age: pregnant women who are younger than 20 or older than 35 are at greater risk

Risk factors for placental abruption include disease, trauma, history, anatomy, and exposure to substances. The risk of placental abruption increases sixfold after severe maternal trauma. Anatomical risk factors include uncommon uterine anatomy (e.g. bicornuate uterus), uterine synechiae, and leiomyoma. Substances that increase risk of placental abruption include cocaine and tobacco when consumed during pregnancy, especially the third trimester. History of placental abruption or previous Caesarian section increases the risk by a factor of 2.3.[11][13][14][15][9]

Pathophysiology

[edit]
Gross pathology of a uterus which has been opened to show a placental abruption, with a hematoma separating the placenta from the uterus.

In the vast majority of cases, placental abruption is caused by the maternal vessels tearing away from the decidua basalis, not the fetal vessels. The underlying cause is often unknown. A small number of abruptions are caused by trauma that stretches the uterus. Because the placenta is less elastic than the uterus, it tears away when the uterine tissue stretches suddenly. When anatomical risk factors are present, the placenta does not attach in a place that provides adequate support, and it may not develop appropriately or be separated as it grows. Cocaine use during the third trimester has a 10% chance of causing abruption. Though the exact mechanism is not known, cocaine and tobacco cause systemic vasoconstriction, which can severely restrict the placental blood supply (hypoperfusion and ischemia), or otherwise disrupt the vasculature of the placenta, causing tissue necrosis, bleeding, and therefore abruption.[9]

In most cases, placental disease and abnormalities of the spiral arteries develop throughout the pregnancy and lead to necrosis, inflammation, vascular problems, and ultimately, abruption. Because of this, most abruptions are caused by bleeding from the arterial supply, not the venous supply. Production of thrombin via massive bleeding causes the uterus to contract and leads to DIC.[9]

The accumulating blood pushes between the layers of the decidua, pushing the uterine wall and placenta apart. When the placenta is separated, it is unable to exchange waste, nutrients, and oxygen, a necessary function for the fetus's survival. The fetus dies when it no longer receives enough oxygen and nutrients to survive.[9]

Diagnosis

[edit]
Ultrasound showing placental abruption

Placental abruption is suspected when a pregnant mother has sudden localized abdominal pain with or without bleeding. The fundus may be monitored because a rising fundus can indicate bleeding. An ultrasound may be used to rule out placenta praevia but is not diagnostic for abruption.[8] The diagnosis is one of exclusion, meaning other possible sources of vaginal bleeding or abdominal pain have to be ruled out in order to diagnose placental abruption.[5] Of note, use of magnetic resonance imaging has been found to be highly sensitive in depicting placental abruption, and may be considered if no ultrasound evidence of placental abruption is present, especially if the diagnosis of placental abruption would change management.[16]

Classification

[edit]

Based on severity:[citation needed]

  • Class 0: Asymptomatic. Diagnosis is made retrospectively by finding an organized blood clot or a depressed area on a delivered placenta.
  • Class 1: Mild and represents approximately 48% of all cases. Characteristics include the following:
    • No vaginal bleeding to mild vaginal bleeding
    • Slightly tender uterus
    • Normal maternal blood pressure and heart rate
    • No coagulopathy
    • No fetal distress
  • Class 2: Moderate and represents approximately 27% of all cases. Characteristics include the following:
    • No vaginal bleeding to moderate vaginal bleeding
    • Moderate-to-severe uterine tenderness with possible tetanic contractions
    • Maternal tachycardia with orthostatic changes in blood pressure and heart rate
    • Fetal distress
    • Hypofibrinogenemia (i.e., 50–250 mg/dL)
  • Class 3: Severe and represents approximately 24% of all cases. Characteristics include the following:
    • No vaginal bleeding to heavy vaginal bleeding
    • Very painful tetanic uterus
    • Maternal shock
    • Hypofibrinogenemia (i.e., <150 mg/dL)
    • Coagulopathy
    • Fetal death

Prevention

[edit]

Although the risk of placental abruption cannot be eliminated, it can be reduced. Avoiding tobacco, alcohol and cocaine during pregnancy decreases the risk. Staying away from activities which have a high risk of physical trauma is also important. Women who have high blood pressure or who have had a previous placental abruption and want to conceive must be closely supervised by a doctor.[17]

The risk of placental abruption can be reduced by maintaining a good diet including taking folate, regular sleep patterns and correction of pregnancy-induced hypertension.[citation needed]

Use of aspirin before 16 weeks of pregnancy to prevent pre-eclampsia also appears effective at preventing placental abruption.[18]

Management

[edit]

Treatment depends on the amount of blood loss and the status of the fetus.[19] If the fetus is less than 36 weeks, and neither mother or fetus are in any distress, then they may simply be monitored in hospital until a change in condition or fetal maturity whichever comes first.[citation needed]

Immediate delivery of the fetus may be indicated if the fetus is mature or if the fetus or mother is in distress. Blood volume replacement to maintain blood pressure and blood plasma replacement to maintain fibrinogen levels may be needed. Vaginal birth is usually preferred over Caesarean section unless there is fetal distress. Caesarean section carries an increased risk in cases of disseminated intravascular coagulation. The mother should be monitored for 7 days for postpartum hemorrhage. Excessive bleeding from uterus may necessitate hysterectomy. The mother may be given Rhogam if she is Rh negative.[citation needed]

Prognosis

[edit]

The prognosis of this complication depends on whether treatment is received by the patient, on the quality of treatment, and on the severity of the abruption. Outcomes for the baby also depend on the gestational age.[5]

In the Western world, maternal deaths due to placental abruption are rare. The fetal prognosis is worse than the maternal prognosis; approximately 12% of fetuses affected by placental abruption die. 77% of fetuses that die from placental abruption die before birth; the remainder die due to complications of preterm birth.[9]

Without any form of medical intervention, as often happens in many parts of the world, placental abruption has a high maternal mortality rate.[citation needed]

Mother

[edit]
  • A large loss of blood may require a blood transfusion.[2]
  • If the mother's blood loss cannot be controlled, an emergency hysterectomy may become necessary.[2]
  • The uterus may not contract properly after delivery so the mother may need medication to help her uterus contract.
  • The mother may develop a blood clotting disorder, disseminated intravascular coagulation.[2]
  • A severe case of shock may affect other organs, such as the liver, kidney, and pituitary gland. Diffuse cortical necrosis in the kidney is a serious and often fatal complication.[2]
  • Placental abruption may cause bleeding through the uterine muscle and into the mother's abdominal cavity, a condition called Couvelaire uterus.[20]
  • Maternal death.[2]

Baby

[edit]
  • The baby may be born at a low birthweight.[2]
  • Preterm delivery (prior to 37 weeks gestation).[2]
  • The baby may be deprived of oxygen and thus develop asphyxia.[2]
  • Placental abruption may also result in death of the baby, or stillbirth.[2]
  • The newborn infant may have learning issues at later development stages, often requiring professional pedagogical aid.

Epidemiology

[edit]

Placental abruption occurs in approximately 0.2–1% of all pregnancies.[8] Though different causes change when abruption is most likely to occur, the majority of placental abruptions occur before 37 weeks gestation, and 12–14% occur before 32 weeks gestation.[8][9]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Placental abruption

View on Grokipedia
from Grokipedia
Placental abruption is the premature separation of the normally implanted from the uterine wall before the delivery of the , a serious obstetric complication that can deprive the of oxygen and nutrients while causing maternal hemorrhage. It is the primary cause of heavy vaginal bleeding before labor in pregnancies with a normally sited placenta; other less common causes include vasa previa, uterine rupture, and local genital tract issues (e.g., cervical polyps, varices, or trauma), which typically cause milder or less frequent heavy bleeding. This condition typically occurs in the second half of , most commonly after 20 weeks of gestation, and affects approximately 0.4% to 1% of pregnancies worldwide. If untreated, it can lead to life-threatening risks for both mother and baby, including fetal demise, , and maternal shock. The exact cause of placental abruption remains unknown in many cases, but it is often associated with the rupture of maternal vessels at the uteroplacental interface, leading to and separation of the placental membranes. Key risk factors include maternal or , which damages vessels; and use, which impair vascular integrity; over 35; previous history of abruption; multiple gestation; and . Other contributors may involve premature , uterine infections, or excessive (). The condition is classified by severity into grades 0 to 3, based on the extent of separation and clinical presentation, with concealed (trapped behind the placenta) complicating up to 20% of cases and increasing diagnostic challenges. Symptoms of placental abruption often include sudden, intense abdominal or , (which may be light or absent if concealed), uterine tenderness or hypertonicity, and frequent . Fetal distress signs, such as abnormal patterns detected via monitoring, are common and signal urgency. relies on clinical suspicion rather than a single definitive test, as has low sensitivity for detecting retroplacental clots; instead, it helps rule out placenta previa, while laboratory tests assess for , , and fetal-maternal hemorrhage. Management prioritizes stabilizing the mother with intravenous fluids, blood transfusions if needed, and continuous fetal monitoring, often requiring immediate delivery—vaginally if possible for stable cases before 37 weeks, or via emergency cesarean section for severe abruption or fetal compromise. Conservative approaches may be used for mild, cases with a viable , involving and close observation, but prompt intervention is critical to mitigate complications like (DIC), postpartum hemorrhage, or renal failure in the mother. The recurrence risk in future pregnancies is 4% to 12%, underscoring the need for preconception counseling and modification, such as . Overall, while maternal mortality has declined with modern care, placental abruption still accounts for 5% to 8% of pregnancy-related deaths and up to 40% of fetal losses in affected cases.

Clinical Presentation

Maternal Signs and Symptoms

Placental abruption often presents with vaginal bleeding, which occurs in approximately 65% to 80% of cases and can be revealed (external) or concealed (internal, trapped behind the placenta). Revealed bleeding is typically dark red if acute or dark and clotted if chronic, with volume varying from spotting to profuse hemorrhage depending on the extent of separation; however, the absence of visible bleeding does not rule out the condition, as concealed bleeding occurs in 20% to 35% of cases. Abdominal pain is a hallmark symptom, often of sudden onset, described as acute, constant, or intermittent, often intense and unrelenting, sometimes likened to a "knife-like" sensation that distinguishes it from typical labor pains due to its non-progressive nature. The pain is frequently accompanied by uterine tenderness on palpation, particularly fundal tenderness, reflecting irritation from the retroplacental hematoma. In cases of concealed bleeding, pain may radiate to the back or shoulders as blood accumulates internally, exacerbating discomfort. Uterine contractions are common and may be frequent and hypertonic, leading to a firm, board-like uterus; in severe cases, they can become tetanic (sustained without relaxation), contributing to further placental compromise. Symptoms of hypovolemia, such as dizziness, tachycardia, and hypotension, arise from significant blood loss, particularly in moderate to severe abruptions where significant blood may accumulate internally before external signs appear. The combination of sudden abdominal pain, fundal tenderness, dark red vaginal bleeding, and fetal hyperactivity at 37 weeks gestation is characteristic of partial placental abruption (partial abruptio placentae), representing an obstetric emergency that requires immediate medical evaluation and likely prompt delivery.

Fetal Signs and Symptoms

Placental abruption can lead to fetal compromise by disrupting oxygen and nutrient supply, manifesting primarily through abnormalities in fetal heart rate monitored via cardiotocography (CTG) or electronic fetal monitoring (EFM). Common patterns include late or variable decelerations, prolonged bradycardia, fetal tachycardia, and loss of variability, which reflect acute hypoxia and reduced uteroplacental perfusion. In severe cases, a sinusoidal or pseudosinusoidal pattern may appear on non-stress testing, characterized by a smooth, undulating waveform indicative of profound fetal anemia or hypoxia, often preceding terminal bradycardia. Reduced fetal movements, as reported by the mother or observed clinically, serve as an early indicator of distress in placental abruption, signaling potential oxygen deprivation and prompting urgent evaluation. Fetal hyperactivity may also occur as an initial sign of fetal compromise in some cases. Signs of fetal hypoxia may include acidosis, detectable through fetal scalp pH sampling where values below 7.20 indicate abnormality and correlate with increased risk of acidemia (pH <7.0 in umbilical artery). Additionally, oligohydramnios observed on ultrasound can occur in chronic abruption cases, contributing to the chronic abruption-oligohydramnios sequence (CAOS) and further compromising fetal well-being. In severe placental abruption, fetal demise may result, evidenced by absence of heart tones on auscultation or monitoring, leading to intrauterine fetal death. Placental abruption accounts for 5% to 10% of all stillbirths, underscoring its role as a major contributor to third-trimester fetal loss. Early detection of these signs through continuous monitoring is critical for timely intervention to mitigate risks.

Etiology and Risk Factors

Underlying Causes

Placental abruption often arises from direct pathophysiological insults that compromise the integrity of the placental attachment to the uterine wall, though the precise trigger remains unidentified in a substantial proportion of cases. Vascular compromise is a primary underlying cause, where rupture or damage to the maternal spiral arteries—key vessels supplying the —leads to hemorrhage and separation. This can occur due to acute , which exerts excessive pressure on vessel walls, or from inherent weaknesses in arterial remodeling during early , resulting in high-resistance blood flow and potential rupture into the decidua basalis. Trauma represents another direct causal mechanism, with placental abruption occurring in approximately 1% to 5% of minor cases during , and up to 50% of cases, typically through blunt abdominal injury from accidents, falls, or physical . The risk is particularly elevated in the third trimester, when the enlarged and thin-walled uterus is more vulnerable to shearing forces that disrupt the uteroplacental interface. Even minor blunt trauma to the abdomen, especially if causing bruising, can lead to placental abruption, which may have delayed onset (typically within 4–24 hours, most cases within 4–9 hours) or initially absent symptoms, risking fetal distress or loss without necessarily involving underlying vascular pathology. Consequently, pregnant individuals experiencing any abdominal trauma in the third trimester should seek immediate medical evaluation, including obstetric assessment, fetal heart monitoring, and checks for vaginal bleeding, contractions, or abdominal pain. Uteroplacental insufficiency triggered by substance use further contributes to abruption by inducing localized hypoxia and vascular spasm. Cocaine, for instance, causes intense of uterine arteries, reducing placental and promoting decidual ; studies from the 1990s, including cohort analyses, reported a 3.9- to 8.6-fold increased risk of abruption among users, approaching a 10-fold elevation in some populations. Similarly, chronic leads to carbon monoxide-induced hypoxia, impairing oxygen delivery and weakening placental adhesion. Inflammatory processes also underlie certain abruptions by eroding the decidual layer that anchors the . Conditions such as chorioamnionitis, an ascending bacterial , or premature initiate neutrophilic infiltration and tissue breakdown, facilitating separation. Histologic evidence confirms that severe accompanies abruption in both preterm and term gestations, often exacerbating and hemorrhage.

Modifiable and Non-Modifiable Risk Factors

Placental abruption is influenced by a range of factors that can be broadly categorized into modifiable and non-modifiable types, with the former amenable to behavioral or interventions and the latter inherent to maternal characteristics or prior . Understanding these distinctions is crucial for targeted and counseling in .

Modifiable Risk Factors

Modifiable factors primarily involve choices and environmental exposures that can be addressed through cessation programs, counseling, or support services. Cigarette smoking during significantly elevates the , with an adjusted odds ratio (AOR) of 1.84 (95% CI: 1.74–1.95), representing approximately a twofold increase compared to non-smokers. Illicit drug use, particularly , poses a substantial , with a pooled odds ratio of 3.92 (95% CI: 2.77–5.46) from a of 11 studies, indicating a nearly fourfold increase. Excessive alcohol consumption also contributes, associated with an odds ratio of 1.48 (95% CI: 1.37–1.60) for placental abruption. Additionally, during is linked to adverse outcomes, including placental abruption, with severe physical or showing an AOR of 1.22 (95% CI: 0.92–1.62), though the association warrants further intervention-focused research.

Non-Modifiable Risk Factors

Non-modifiable risk factors stem from genetic, demographic, or historical elements that cannot be altered but can inform heightened surveillance. over 35 years increases the with an AOR of 1.42 (95% CI: 1.22–1.65), about a 1.5-fold elevation. A history of previous placental abruption markedly raises recurrence to 10-15% in subsequent pregnancies, with an AOR of 2.72 (95% CI: 2.16–3.42). Multiple gestation pregnancies carry a 1.5- to 2-fold higher compared to singletons. Short umbilical cord length is an independent , though specific quantitative associations require further validation. Preterm premature (PPROM) is associated with a significant of subsequent abruption, particularly in expectantly managed cases. similarly heightens the likelihood, as evidenced by a confirming it as a for placental separation. approximately doubles the , with an AOR of 2.45 (95% CI: 2.09–2.86). African American is associated with a 44% higher incidence (1.02% vs. 0.71% in white women). Emerging evidence from recent studies identifies inherited thrombophilias as a non-modifiable factor, with an of approximately 2.5 for placental abruption.

Pathophysiology

Mechanisms of Placental Separation

Placental abruption initiates with the rupture of maternal decidual vessels in the basalis layer of the , leading to bleeding that accumulates as a between the and the uterine wall. This initial hemorrhage disrupts the normal attachment, forming a retroplacental clot that begins the separation process. The rupture often stems from vascular fragility exacerbated by factors such as or trauma, though the precise inciting event varies. As the expands, it generates due to the differing elasticity between the and the , propagating further separation. This mechanical force can lead to marginal abruption, where separation occurs at the placental edge; central abruption, involving the central portion; or complete abruption, with total detachment. The expanding blood collection compresses l tissue, compromising nutrient and oxygen exchange, and the process typically begins at or after 20 weeks of . Abruptions are classified by bleeding presentation as revealed or concealed. In revealed abruption, blood tracks through the to the , resulting in visible vaginal hemorrhage. Concealed abruption, occurring in 20-35% of cases, involves trapped within the behind the , often going undetected and posing greater risk due to unrecognized maternal loss and fetal . The severity of abruption correlates with the extent of placental separation, where smaller separations cause mild effects and larger ones lead to severe outcomes including profound and fetal distress.

Hemodynamic and Coagulation Effects

Placental abruption results in acute blood loss from the separation of the placental attachment, which can rapidly lead to maternal due to significant . In severe cases, this shock manifests as , , and , with the degree of often exceeding the visible external blood loss. Concealed abruption, where occurs behind the without vaginal manifestation, can result in significant unrecognized maternal blood loss, exacerbating the risk of undetected and shock. In developed countries, placental abruption contributes to 1-5% of maternal deaths, primarily from hemorrhagic complications. The cascade is profoundly disrupted in placental abruption, with (DIC) occurring in approximately 10% of cases, particularly severe ones. This process involves widespread activation of , leading to consumptive characterized by , where platelets are depleted through excessive clotting and . Laboratory hallmarks of DIC in this context include fibrinogen levels below 200 mg/dL, indicating severe depletion, and markedly elevated levels reflecting degradation. Fetal effects stem from the reduced uteroplacental caused by the abruption, resulting in acute hypoxia and potential distress. In severe instances, blood from the retroplacental may extravasate into the , producing the , a condition marked by intramural hemorrhage that further impairs uterine contractility and oxygenation.

Diagnosis

Clinical Evaluation

Clinical evaluation of placental abruption begins with a thorough history to identify risk factors and symptoms suggestive of the condition. Patients often report sudden onset of severe abdominal or , which may precede , along with a history of trauma, , , or use. In particular, a history of recent blunt trauma—even minor trauma causing bruising, especially to the abdomen—in the third trimester warrants prompt medical evaluation, even in currently asymptomatic patients, due to the risk of placental abruption with delayed or concealed presentation that can lead to fetal distress or loss. Immediate assessment in such cases includes continuous fetal heart rate monitoring, evaluation for uterine contractions, and checks for vaginal bleeding and abdominal pain. Screening for prior placental abruption or other obstetric complications is essential, as recurrence rates range from 3% to 10%. A high index of suspicion is warranted in multiparous women, who face an elevated risk due to factors such as and previous pregnancies. Approximately one-third of episodes in the third trimester are attributable to placental abruption, underscoring the need for prompt assessment in any such presentation. Physical examination focuses on vital signs and abdominal assessment to detect hypovolemia and uterine involvement. Tachycardia exceeding 100 beats per minute and hypotension below 90/60 mmHg indicate significant blood loss, particularly in cases of concealed hemorrhage where external bleeding is absent. Abdominal palpation typically reveals a tender, firm, "woody hard" or board-like uterus due to tetanic contractions, contrasting with the softer uterus in other causes of bleeding. Auscultation for fetal heart tones is critical, as decelerations or bradycardia signal fetal distress. Uterine hypertonus without relaxation between contractions further supports suspicion of abruption. Differential diagnosis of antepartum bleeding includes preterm labor, placenta previa, vasa previa, uterine rupture, and local genital tract issues (e.g., cervical polyps, varices, or trauma). When placenta previa has been ruled out by ultrasound confirming a normally sited placenta, placental abruption is the primary cause of heavy vaginal bleeding before labor. Other causes such as vasa previa, uterine rupture, and local genital tract issues typically result in milder or less frequent heavy bleeding compared to abruption. Distinctions are based on clinical features including pain, bleeding characteristics, and ultrasound findings. Unlike the painless, bright red bleeding typical of placenta previa or vasa previa (which are excluded by ultrasound demonstrating normal placental location and absence of aberrant vessels), abruption often presents with pain preceding or accompanying dark, clotted vaginal bleeding in about 80% of cases, with the remainder concealed. Uterine rupture is characterized by severe abdominal pain and potential hemodynamic instability. Local genital tract issues usually cause spotting or mild bleeding, often post-coital or post-trauma. Preterm labor may mimic abruption through contractions but lacks the characteristic uterine rigidity and tenderness. Abruption is suspected when pain intensity correlates with the extent of separation, prompting immediate further evaluation. In concealed cases, the absence of visible bleeding heightens reliance on historical and physical clues tied to underlying vascular disruption.

Imaging and Laboratory Tests

Ultrasound is the primary imaging modality for evaluating suspected placental abruption, typically revealing a retroplacental hypoechoic or heterogeneous area indicative of formation. However, its sensitivity ranges from 25% to 57% for detecting abruptions, particularly small or concealed ones, making it unreliable for ruling out the condition in clinically suspicious cases. excels in specificity, often approaching 100%, and is essential for excluding placenta previa by confirming placental location. Magnetic resonance imaging (MRI) serves as an emerging adjunct for cases with high clinical suspicion but negative ultrasound findings, especially concealed abruptions where blood accumulates behind the placenta without vaginal bleeding. MRI demonstrates high sensitivity, up to 97%, in depicting placental separation and hematoma, with excellent interobserver agreement, though it is not routinely used due to cost, availability, and time constraints. Fetal monitoring is critical to assess for distress secondary to abruption. Continuous (electronic fetal monitoring) detects nonreassuring fetal patterns, such as decelerations or reduced variability, indicating compromise. The , combining assessment of fetal breathing, movement, tone, amniotic fluid volume, and results, provides a comprehensive score (0-10) to evaluate fetal , with scores below 6 signaling need for intervention. Laboratory tests support diagnosis by quantifying blood loss and complications. Complete blood count (CBC) identifies maternal anemia, with hemoglobin levels below 10 g/dL suggesting significant hemorrhage. Coagulation studies, including prothrombin time (PT), partial thromboplastin time (PTT), and fibrinogen levels, screen for disseminated intravascular coagulation (DIC), where fibrinogen often falls below 200 mg/dL. The Kleihauer-Betke test quantifies fetomaternal hemorrhage by detecting fetal red blood cells in maternal circulation, guiding Rho(D) immune globulin dosing in Rh-negative patients if more than 30 mL fetal blood is estimated. Severity classification integrates , monitoring, and findings into grades 0 to 3 based on clinical . Grade 0 is asymptomatic with a retroplacental clot found retrospectively at delivery. Grade 1 (mild) features no or minimal , mild uterine tenderness, and normal maternal and fetal . Grade 2 (moderate) involves no to moderate or concealed hemorrhage, uterine hypertonus, maternal , nonreassuring fetal patterns, and mild (e.g., hypofibrinogenemia). Grade 3 (severe) includes heavy or absent (concealed) bleeding, a board-like , maternal shock or , fetal demise, and significant or DIC (e.g., fibrinogen <200 mg/dL, prolonged PT/PTT).

Management

Initial Stabilization

Upon suspicion of placental abruption, initial stabilization prioritizes rapid assessment and supportive measures to preserve maternal hemodynamic stability and fetal oxygenation, guided by clinical findings such as vaginal bleeding or uterine tenderness. Maternal care begins with establishing two large-bore intravenous (IV) lines, typically 16- or 18-gauge, to facilitate fluid resuscitation and potential blood product administration. Crystalloid fluids, such as normal saline or lactated Ringer's solution, are administered initially at 1-2 liters to restore intravascular volume and counteract hypovolemia from hemorrhage. If estimated blood loss exceeds 1500 mL or maternal hypotension persists after initial fluid bolus, blood transfusion is indicated, with type and crossmatch performed concurrently to prepare for packed red blood cells. For Rh-negative mothers, administration of Rho(D) immune globulin (RhoGAM) is essential to prevent isoimmunization, with dosing guided by the Kleihauer-Betke test to quantify fetomaternal hemorrhage.00535-X/fulltext)00065-9/fulltext) Fetal well-being is supported by providing supplemental oxygen to the mother via at 10-15 liters per minute to maximize maternal and placental transfer. Placing the patient in the left lateral position alleviates aortocaval compression, improving uterine blood flow and fetal . In cases of preterm with stable maternal and no evidence of fetal distress, short-term tocolysis may be considered using agents like to allow time for corticosteroid administration; however, tocolysis is contraindicated in severe abruption with maternal or fetal , per guidelines from the American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine (SMFM).31212-7/fulltext) Continuous monitoring is critical throughout stabilization, including maternal (heart rate, , , ), fetal via external electronic monitoring to detect or decelerations, and urine output via indwelling targeting greater than 30 mL per hour to assess renal and ongoing .00535-X/fulltext)

Definitive Treatment and Delivery

The definitive treatment for placental abruption is prompt delivery of the fetus and to halt ongoing separation and mitigate risks to maternal and fetal . The decision between expectant and immediate delivery hinges on abruption severity, , and stability of maternal and fetal . In mild cases (class 1) with stable conditions and under 34 weeks, expectant may be appropriate, involving monitoring, fetal , and administration of antenatal corticosteroids to enhance fetal maturity, while avoiding tocolysis if fetal compromise is suspected. However, for moderate (class 2) or severe (class 3) abruptions, or any abruption at or beyond 34 weeks , immediate delivery is mandated to prevent progression to or fetal demise. When maternal and fetal status permit, remains the preferred route due to its lower risk of surgical complications and faster maternal recovery. Labor or augmentation with oxytocin and amniotomy can be employed to expedite vaginal birth if cervical ripening allows and no contraindications exist, provided continuous fetal monitoring confirms tolerance. Cesarean delivery is indicated for emergent situations involving acute fetal distress, maternal such as refractory , or failed progress toward , and is performed in the majority of severe cases to optimize outcomes. Current guidelines recommend a decision-to-incision interval of under 30 minutes for category I cesareans to minimize perinatal hypoxia, with a multidisciplinary team prepared for potential coagulopathy-related challenges like vertical uterine incision if needed.00461-6/fulltext) Adjunctive interventions support delivery efforts and address associated risks. is administered for fetal in anticipated preterm deliveries before 32 weeks , reducing risk based on established protocols. is a rare but life-saving option reserved for uncontrollable postpartum hemorrhage unresponsive to uterotonics, uterine , and transfusion. A dedicated team is mandatory at delivery to manage potential or prematurity-related issues.

Prognosis and Complications

Maternal Prognosis

In high-resource settings, maternal mortality from placental abruption is less than 1%, though it accounts for approximately 6% of maternal deaths worldwide when resources are limited. Short-term complications include postpartum hemorrhage, which occurs in up to 50% of cases and often requires blood transfusions (rates of 11-38%). develops in about 10-20% of severe cases, leading to and increased bleeding risk. Acute renal failure, typically from , affects a smaller subset but is usually reversible with prompt intervention. Long-term outcomes reveal elevated risks for subsequent pregnancies, including a 2-fold increase in . Recurrent abruption occurs in 10-15% of future gestations, rising to 25% after two prior events. , needed in severe cases for uncontrollable hemorrhage ( 2.8-7.9), can result in . mortality is 2.65 times higher long-term compared to unaffected women. Prognosis depends on abruption severity, at onset, and treatment timeliness; concealed abruptions (20-35% of cases) carry worse outcomes due to hidden bleeding and delayed recognition. Recent 2025 data indicate approximately 4% of affected women require admission for stabilization, with rates up to 7% in preterm cases.

Fetal and Neonatal Prognosis

Placental abruption significantly impacts fetal and neonatal outcomes, primarily due to acute hypoxia from disrupted placental blood flow and associated prematurity. rates range from 10% to 30% overall, rising to as high as 50% in severe cases characterized by extensive placental separation or concealed hemorrhage. These deaths are largely attributable to fetal hypoxia leading to or neonatal demise shortly after birth, with recent analyses indicating a rate of approximately 15% in affected pregnancies. Outcomes improve markedly with advancing , with survival rates exceeding 90% when abruption occurs after 37 weeks compared to under 50% before 34 weeks. Neonates who survive placental abruption face heightened risks of immediate complications stemming from prematurity and . Respiratory distress syndrome affects around 40% of these infants, often necessitating and prolonged stays. occurs more frequently in very low birth weight infants exposed to abruption, with adjusted odds ratios indicating a 1.5- to 2-fold increase compared to non-abruption controls. Additionally, the risk of is elevated 5- to 10-fold in survivors, linked to hypoxic-ischemic brain injury during the event. Long-term sequelae in survivors include neurodevelopmental delays, such as cognitive impairments and motor deficits, observed in up to 20% of cases depending on the severity of hypoxia. Chronic or recurrent abruption may also contribute to , resulting in smaller birth weights and potential persistent growth issues into childhood. These outcomes underscore the importance of timely intervention to mitigate hypoxic exposure and support neonatal recovery.

Aspects

Epidemiology

Placental abruption occurs in approximately 0.6% to 1.2% of pregnancies worldwide, equating to about 1 in 100 deliveries. , the incidence has risen from 1.2% in 2000 to 1.6% in 2020, while rates in can reach 1.5% or higher, with some studies reporting up to 2.4% in specific regions like . In low-resource settings, the incidence may climb to 2% or more due to limited access to . Overall trends in placental abruption incidence have remained relatively stable globally, though rates are increasing in association with rising maternal age at delivery and higher prevalence of risk factors like hypertension. A 2025 systematic review reports a worldwide incidence of 0.6% to 1.2%. Demographically, placental abruption is more common among Black women, with rates approximately 1.3 times higher than in White women, even after adjusting for socioeconomic factors. Incidence peaks in women aged 20 to 35 years, though risks elevate at both extremes of reproductive age, particularly above 35. It occurs more frequently in multiparous women compared to nulliparous individuals. Placental abruption accounts for about 30% of third-trimester episodes. Some studies indicate seasonal variations, with higher incidence reported in spring and autumn months in certain populations. Placental abruption accounts for approximately 6% of maternal deaths worldwide as of 2025.

Prevention Strategies

Preventing placental abruption primarily involves addressing modifiable risk factors through modifications, interventions, and enhanced antenatal care, particularly for high-risk pregnancies such as those with a history of prior abruption. While no routine screening test exists for placental abruption, evidence-based strategies can significantly lower incidence by targeting behaviors and conditions like , substance use, , and . Lifestyle interventions form the cornerstone of prevention. Smoking during pregnancy doubles the risk of placental abruption, but cessation can reduce this risk compared to continued use, as quitting eliminates the vascular and thrombotic effects of . Similarly, avoiding cocaine use is critical, as it increases abruption risk through and placental ischemia, with studies showing up to a fourfold in exposed pregnancies. Alcohol consumption has weaker direct associations but should be avoided to minimize overall pregnancy complications. Maintaining a healthy weight is also recommended, as maternal elevates abruption risk via chronic and vascular strain, and preconception or early can mitigate this. Medical management targets underlying conditions that heighten risk. Effective treatment of chronic hypertension, including blood pressure control to below 140/90 mm Hg, reduces abruption incidence by preventing vascular damage to the placenta. For high-risk cases, such as those with preeclampsia history, the American College of Obstetricians and Gynecologists (ACOG) recommends low-dose aspirin prophylaxis at 81 mg daily starting from 12 weeks of gestation, which primarily prevents preeclampsia but has not been shown to directly alter abruption risk. Screening for and addressing domestic violence is essential, as physical trauma from intimate partner violence is a known precipitant of abruption, and routine antenatal inquiry with referral to support services can prevent such incidents. Antenatal care emphasizes vigilant monitoring for high-risk individuals. Women with a previous placental abruption require early and frequent prenatal visits with fetal , such as non-stress tests from 32 weeks, to detect early signs of recurrence and enable timely intervention. For those with a short (less than 25 mm) identified on transvaginal , vaginal progesterone supplementation from 16 to 36 weeks reduces risk, which indirectly safeguards against abruption-related complications in vulnerable pregnancies. These strategies, when implemented comprehensively, align with 2025 guidelines prioritizing risk reduction without increasing adverse events like , with emphasis on tailored approaches in high-incidence regions such as . Antenatal care should also include patient education on injury prevention and response to trauma. Pregnant individuals should be counseled on proper seat belt use during motor vehicle travel, with the lap belt positioned as low as possible under the abdomen and the shoulder belt placed off the uterus between the breasts, to reduce risks from collisions. Furthermore, in the third trimester, any trauma resulting in bruising—especially to the abdomen—requires immediate medical evaluation, as even minor blunt trauma can cause placental abruption that may initially lack symptoms but poses risks of fetal distress or loss. Prompt assessment by an obstetrician, emergency department, or maternity unit is recommended, including fetal heart monitoring and checks for vaginal bleeding, contractions, or abdominal pain.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK482335/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC9101673/
  3. https://www.mayoclinic.org/diseases-conditions/placental-abruption/symptoms-causes/syc-20376458
  4. https://www.dynamed.com/condition/placental-abruption
  5. https://my.clevelandclinic.org/health/diseases/9435-placental-abruption
  6. https://www.ajog.org/article/S0002-9378(22)00535-X/fulltext
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC8169476/
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC3735466/
  9. https://pubmed.ncbi.nlm.nih.gov/9610464/
  10. https://www.acog.org/clinical/clinical-guidance/obstetric-care-consensus/articles/2020/03/management-of-stillbirth
  11. https://obgyn.onlinelibrary.wiley.com/doi/full/10.3109/00016341003686081
  12. https://www.ncbi.nlm.nih.gov/books/NBK430926/
  13. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/j.1600-0412.2010.01030.x
  14. https://www.jtraumainj.org/journal/view.php?number=1331
  15. https://www.aafp.org/pubs/afp/issues/2014/1115/p717.html
  16. https://www.jogc.com/article/S1701-2163(15)30232-2/pdf
  17. https://academic.oup.com/aje/article-abstract/133/8/818/65141
  18. https://pubmed.ncbi.nlm.nih.gov/17826437/
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC11938633/
  20. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1360-0443.1997.tb02874.x
  21. https://www.ajog.org/article/S0002-9378%2821%2900745-6/abstract
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC6420388/
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC11646271/
  24. https://fetalmedicine.org/abstracts/2014/abstracts/321.pdf
  25. https://pubmed.ncbi.nlm.nih.gov/7856704/
  26. https://pubmed.ncbi.nlm.nih.gov/30624999/
  27. https://www.ajog.org/article/S0002-9378%2807%2901485-8/fulltext
  28. https://www.researchgate.net/publication/24243137_The_Effect_of_Maternal_Thrombophilia_on_Placental_Abruption_Histologic_Correlates
  29. https://www.uptodate.com/contents/acute-placental-abruption-pathophysiology-clinical-features-diagnosis-and-consequences
  30. https://www.glowm.com/section-view/heading/Placental%2520Abruption/item/122
  31. https://www.nysora.com/anesthesia/placental-abruption/
  32. https://jmedicalcasereports.biomedcentral.com/articles/10.1186/1752-1947-8-461
  33. https://emedicine.medscape.com/article/252810-workup
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC9188327/
  35. https://emedicine.medscape.com/article/252810-overview
  36. https://obgyn.mhmedical.com/content.aspx?bookid=498&sectionid=41008608
  37. https://www.jogc.com/article/s1701-2163(15)30232-2/pdf
  38. https://www.unboundmedicine.com/5minute/view/5-Minute-Clinical-Consult/816105/1.1/Abruptio_Placentae
  39. https://emedicine.medscape.com/article/252810-differential
  40. https://www.aafp.org/pubs/afp/issues/2007/0415/p1199.html
  41. https://www.rcog.org.uk/media/pwdi1tef/gtg_63.pdf
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC5028521/
  43. https://emedicine.medscape.com/article/402314-overview
  44. https://pubmed.ncbi.nlm.nih.gov/21330568/
  45. https://www.ncbi.nlm.nih.gov/books/NBK537123/
  46. https://www.merckmanuals.com/professional/gynecology-and-obstetrics/antenatal-complications/placental-abruption-abruptio-placentae
  47. https://www.ncbi.nlm.nih.gov/books/NBK430876/
  48. https://emedicine.medscape.com/article/252810-treatment
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC7482995/
  50. https://www.mayoclinic.org/diseases-conditions/placental-abruption/diagnosis-treatment/drc-20376462
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC5683164/
  52. https://onlinelibrary.wiley.com/doi/abs/10.1111/ppe.12184
  53. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-025-07718-6
  54. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-025-07482-7
  55. https://pubmed.ncbi.nlm.nih.gov/40940025/
  56. https://medcraveonline.com/OGIJ/placental-abruption-a-five-year-review-of-prevalence-risk-factors-and-foeto-maternal-outcomes-in-a-tertiary-hospital-enugu-nigeria.html
  57. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0125246
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC2546363/
  59. https://pubmed.ncbi.nlm.nih.gov/8841208/
  60. https://www.merckmanuals.com/professional/gynecology-and-obstetrics/symptoms-during-pregnancy/vaginal-bleeding-during-late-pregnancy
  61. https://pubmed.ncbi.nlm.nih.gov/22524630/
  62. https://www.tommys.org/pregnancy-information/pregnancy-complications/placenta-complications/placental-abruption
  63. https://academic.oup.com/aje/article/166/3/289/116643
  64. https://www.sciencedirect.com/science/article/abs/pii/S0890623801001368
  65. https://www.sciencedirect.com/science/article/abs/pii/S0301211520304607
  66. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2018/07/low-dose-aspirin-use-during-pregnancy
  67. https://www.obgproject.com/2018/01/19/can-aspirin-decrease-risk-placental-abruption-antepartum-hemorrhage/
  68. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/06/indications-for-outpatient-antenatal-fetal-surveillance
  69. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2023/04/updated-guidance-use-of-progestogen-supplementation-for-prevention-of-recurrent-preterm-birth
  70. https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/uog.27472
Add your contribution
Related Hubs
User Avatar
No comments yet.